| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |